Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gomez-Sanchez, M.
Right arrow Articles by Martinez-Tello, F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Gomez-Sanchez, M.
Right arrow Articles by Martinez-Tello, F.

Chest, Vol 95, 325-331, Copyright © 1989 by American College of Chest Physicians


ARTICLES

Pulmonary hypertension due to toxic oil syndrome. A clinicopathologic study

MA Gomez-Sanchez, MJ Mestre de Juan, C Gomez-Pajuelo, JI Lopez, MJ Diaz de Atauri and FJ Martinez-Tello
Cardiology Service, Hospital 1. de Octubre, Madrid, Spain.

Clinical and pathologic findings in seven patients who died of severe pulmonary artery hypertension due to toxic oil syndrome are assessed. These cases correspond to a late stage of evolution of the disease characterized by progressive deterioration in clinical features-- increasing dyspnea, chest pain, syncope, and death (in low-output heart failure). The main pathologic pulmonary vascular findings consisted of plexiform lesions, thromboses, and venous lesions. Endothelial damage induced by the toxic agents is suggested as an initial causative mechanism, perpetuated by intimal proliferation and in situ thrombosis. Plexiform lesions appear late and active histologically. This new cause of pulmonary artery hypertension, with pathologic findings similar to those found in primary pulmonary hypertension, may help in understanding the pathophysiology of this unknown disease.


This article has been cited by other articles:


Home page
Eur Respir JHome page
A. Widlitz and R.J. Barst
Pulmonary arterial hypertension in children
Eur. Respir. J., January 1, 2003; 21(1): 155 - 176.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the American College of Chest Physicians.